Bile Acid [EPC]

Bile Acid [EPC] was reported 23057 times

These side effects are most commonly reported by patients taking drugs of the Bile Acid [EPC] class:

# Drug class Count
0 OFF LABEL USE 1852
1 DIARRHOEA 1381
2 PRURITUS 1335
3 FATIGUE 1135
4 NAUSEA 1108
5 PYREXIA 1045
6 DRUG INEFFECTIVE 1005
7 PNEUMONIA 803
8 DEATH 783
9 VOMITING 763
10 HEADACHE 662
11 DYSPNOEA 618
12 RASH 586
13 ABDOMINAL PAIN 584
14 DECREASED APPETITE 573
15 ANAEMIA 538
16 ASTHENIA 536
17 DIZZINESS 527
18 MALAISE 510
19 PAIN 475
20 WEIGHT DECREASED 475
21 ALANINE AMINOTRANSFERASE INCREASED 472
22 FEBRILE NEUTROPENIA 465
23 ARTHRALGIA 460
24 COUGH 459
25 PLATELET COUNT DECREASED 457
26 CONSTIPATION 456
27 SEPSIS 455
28 CONDITION AGGRAVATED 451
29 ASPARTATE AMINOTRANSFERASE INCREASED 439
30 ACUTE KIDNEY INJURY 432
31 HEPATIC FUNCTION ABNORMAL 420
32 PRODUCT DOSE OMISSION ISSUE 404
33 ABDOMINAL PAIN UPPER 401
34 LIVER DISORDER 391
35 BLOOD BILIRUBIN INCREASED 390
36 HEPATIC FAILURE 377
37 ASCITES 374
38 THROMBOCYTOPENIA 372
39 FALL 356
40 WEIGHT INCREASED 342
41 INFECTION 341
42 BLOOD ALKALINE PHOSPHATASE INCREASED 338
43 HYPERTENSION 338
44 RENAL FAILURE 334
45 NEUTROPENIA 330
46 HOSPITALISATION 323
47 INSOMNIA 316
48 HYPOTENSION 313
49 MUCOSAL INFLAMMATION 309
50 PRODUCT USE IN UNAPPROVED INDICATION 301
51 HEPATIC ENZYME INCREASED 300
52 VENOOCCLUSIVE LIVER DISEASE 295
53 WHITE BLOOD CELL COUNT DECREASED 289
54 ABDOMINAL DISTENSION 284
55 COVID-19 281
56 DRUG INTERACTION 280
57 MATERNAL EXPOSURE DURING PREGNANCY 271
58 OEDEMA PERIPHERAL 270
59 RENAL IMPAIRMENT 270
60 URINARY TRACT INFECTION 260
61 BACK PAIN 259
62 ANXIETY 258
63 DEHYDRATION 258
64 HAEMOGLOBIN DECREASED 257
65 PAIN IN EXTREMITY 257
66 RESPIRATORY FAILURE 256
67 ABDOMINAL DISCOMFORT 248
68 PLEURAL EFFUSION 247
69 JAUNDICE 246
70 INTERSTITIAL LUNG DISEASE 244
71 DISEASE PROGRESSION 243
72 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 239
73 SEPTIC SHOCK 237
74 SOMNOLENCE 235
75 NASOPHARYNGITIS 231
76 APLASTIC ANAEMIA 229
77 PANCYTOPENIA 227
78 PRODUCT USE ISSUE 227
79 HEPATIC CIRRHOSIS 225
80 MULTIPLE ORGAN DYSFUNCTION SYNDROME 225
81 BLOOD PRESSURE INCREASED 215
82 CONFUSIONAL STATE 215
83 DEPRESSION 213
84 FOETAL EXPOSURE DURING PREGNANCY 213
85 CHEST PAIN 212
86 GAMMA-GLUTAMYLTRANSFERASE INCREASED 210
87 INFLUENZA 204
88 STOMATITIS 202
89 DRUG-INDUCED LIVER INJURY 201
90 ALOPECIA 199
91 MYALGIA 195
92 GENERAL PHYSICAL HEALTH DETERIORATION 192
93 VENOOCCLUSIVE DISEASE 191
94 THERAPY INTERRUPTED 189
95 GASTROINTESTINAL HAEMORRHAGE 188
96 CHOLESTASIS 187
97 BLOOD CREATININE INCREASED 185
98 HEPATIC ENCEPHALOPATHY 185
99 PERIPHERAL SWELLING 184
100 FEELING ABNORMAL 183
101 TOXICITY TO VARIOUS AGENTS 180
102 TREMOR 174
103 NEUTROPHIL COUNT DECREASED 171
104 CHILLS 168
105 ERYTHEMA 168
106 GAIT DISTURBANCE 166
107 CHOLELITHIASIS 165
108 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 165
109 EPISTAXIS 161
110 CHOLANGITIS 159
111 MUSCLE SPASMS 158
112 CARDIAC FAILURE 157
113 GASTROINTESTINAL DISORDER 156
114 HYPOKALAEMIA 154
115 EXPOSURE DURING PREGNANCY 152
116 GRAFT VERSUS HOST DISEASE 148
117 CYTOKINE RELEASE SYNDROME 147
118 CYSTIC FIBROSIS 146
119 HYPERSENSITIVITY 144
120 PREMATURE BABY 144
121 BLOOD GLUCOSE INCREASED 137
122 NEUROPATHY PERIPHERAL 137
123 OROPHARYNGEAL PAIN 137
124 INTENTIONAL PRODUCT USE ISSUE 135
125 HYPERBILIRUBINAEMIA 134
126 ACUTE GRAFT VERSUS HOST DISEASE 132
127 ATRIAL FIBRILLATION 131
128 COLITIS ULCERATIVE 131
129 THERAPY CESSATION 131
130 DYSPEPSIA 130
131 HAEMORRHAGE 130
132 MUSCULAR WEAKNESS 130
133 SEIZURE 130
134 URTICARIA 129
135 CHEST DISCOMFORT 128
136 ILLNESS 128
137 HYPONATRAEMIA 127
138 MALIGNANT NEOPLASM PROGRESSION 127
139 HAEMATOCHEZIA 126
140 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 126
141 LIVER FUNCTION TEST INCREASED 125
142 LOSS OF CONSCIOUSNESS 125
143 CONTUSION 123
144 GASTROOESOPHAGEAL REFLUX DISEASE 123
145 HYPOXIA 123
146 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 122
147 DYSPHAGIA 121
148 DRUG DOSE OMISSION 120
149 HEPATIC NEOPLASM MALIGNANT 120
150 OEDEMA 120
151 CROHN^S DISEASE 118
152 RENAL FAILURE ACUTE 118
153 DISSEMINATED INTRAVASCULAR COAGULATION 117
154 DRUG HYPERSENSITIVITY 117
155 BLOOD PRESSURE DECREASED 116
156 HEPATITIS 115
157 TACHYCARDIA 114
158 DRY MOUTH 113
159 DIABETES MELLITUS 112
160 HYPOAESTHESIA 112
161 MEMORY IMPAIRMENT 111
162 CARDIAC ARREST 110
163 THERAPY NON-RESPONDER 110
164 HEART RATE INCREASED 109
165 INJECTION SITE PAIN 109
166 PANCREATITIS ACUTE 108
167 CYTOMEGALOVIRUS INFECTION 107
168 HYPERGLYCAEMIA 107
169 SINUSITIS 107
170 C-REACTIVE PROTEIN INCREASED 106
171 DRY SKIN 106
172 HYPOTHYROIDISM 105
173 TRANSAMINASES INCREASED 105
174 PALPITATIONS 104
175 ASTHMA 103
176 ENCEPHALOPATHY 102
177 FLATULENCE 102
178 BLOOD LACTATE DEHYDROGENASE INCREASED 101
179 NEPHROLITHIASIS 101
180 CELLULITIS 100
181 CHOLANGITIS SCLEROSING 100
182 FLUID RETENTION 99
183 RENAL DISORDER 99
184 ACUTE RESPIRATORY DISTRESS SYNDROME 98
185 RHINORRHOEA 98
186 DRUG INTOLERANCE 97
187 FREQUENT BOWEL MOVEMENTS 97
188 PANCREATITIS 97
189 PRODUCTIVE COUGH 97
190 BONE PAIN 96
191 INFUSION RELATED REACTION 96
192 SLEEP DISORDER 96
193 OXYGEN SATURATION DECREASED 95
194 PRODUCT DOSE OMISSION 95
195 LIVER FUNCTION TEST ABNORMAL 94
196 STAPHYLOCOCCAL INFECTION 94
197 TOXIC EPIDERMAL NECROLYSIS 94
198 SYNCOPE 93
199 CEREBRAL HAEMORRHAGE 92
200 PERICARDIAL EFFUSION 92
201 PULMONARY EMBOLISM 92
202 BRONCHITIS 91
203 PULMONARY OEDEMA 91
204 RHABDOMYOLYSIS 91
205 CHRONIC KIDNEY DISEASE 90
206 DEPRESSED LEVEL OF CONSCIOUSNESS 90
207 HAEMATEMESIS 90
208 HYPOALBUMINAEMIA 90
209 INTESTINAL OBSTRUCTION 90
210 LIVER TRANSPLANT 88
211 HERPES ZOSTER 87
212 INCORRECT DOSE ADMINISTERED 87
213 JOINT SWELLING 87
214 MYOCARDIAL INFARCTION 86
215 PORTAL HYPERTENSION 86
216 THROMBOSIS 86
217 PARAESTHESIA 85
218 BACTERAEMIA 84
219 BLOOD UREA INCREASED 84
220 MULTI-ORGAN FAILURE 84
221 CEREBROVASCULAR ACCIDENT 83
222 RED BLOOD CELL COUNT DECREASED 83
223 FLUSHING 82
224 THROMBOTIC MICROANGIOPATHY 82
225 VIRAL INFECTION 82
226 BLOOD ALKALINE PHOSPHATASE ABNORMAL 81
227 BLOOD CREATINE PHOSPHOKINASE INCREASED 81
228 CARDIAC FAILURE CONGESTIVE 81
229 COLITIS 81
230 HEPATIC FIBROSIS 81
231 HYPOGLYCAEMIA 81
232 LUNG DISORDER 81
233 PREMATURE DELIVERY 81
234 SPLENOMEGALY 81
235 VISUAL IMPAIRMENT 81
236 WHITE BLOOD CELL COUNT INCREASED 80
237 HAEMOPTYSIS 79
238 HEPATIC CYTOLYSIS 79
239 HYPERKALAEMIA 79
240 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 78
241 ADVERSE DRUG REACTION 78
242 AUTOIMMUNE HEPATITIS 78
243 BALANCE DISORDER 78
244 DRY EYE 78
245 HEPATOMEGALY 78
246 HEPATOTOXICITY 78
247 DYSPNOEA EXERTIONAL 77
248 ECZEMA 77
249 LETHARGY 77
250 RESPIRATORY DISTRESS 76
251 VISION BLURRED 76
252 DYSPHONIA 75
253 RASH PRURITIC 75
254 VARICES OESOPHAGEAL 75
255 HYPERHIDROSIS 74
256 ACUTE RESPIRATORY FAILURE 73
257 ANAPHYLACTIC REACTION 73
258 CHROMATURIA 73
259 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 73
260 MELAENA 73
261 MENTAL STATUS CHANGES 73
262 VASCULAR DEVICE INFECTION 73
263 ARTHRITIS 72
264 BACTERIAL INFECTION 72
265 BLOOD ALBUMIN DECREASED 72
266 CLOSTRIDIUM DIFFICILE INFECTION 72
267 FUNGAL INFECTION 72
268 URINARY RETENTION 72
269 TREATMENT NONCOMPLIANCE 71
270 CYTOPENIA 70
271 LYMPHOCYTE COUNT DECREASED 70
272 AGRANULOCYTOSIS 69
273 COAGULOPATHY 68
274 SWELLING 68
275 LIVER INJURY 67
276 DELIRIUM 66
277 GASTRIC ULCER 66
278 RECTAL HAEMORRHAGE 66
279 RHEUMATOID ARTHRITIS 66
280 MYELOSUPPRESSION 65
281 PSEUDOMONAS INFECTION 65
282 UPPER RESPIRATORY TRACT INFECTION 65
283 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 65
284 HYPOMAGNESAEMIA 64
285 INTERNATIONAL NORMALISED RATIO INCREASED 64
286 LABORATORY TEST ABNORMAL 64
287 MUSCULOSKELETAL STIFFNESS 64
288 NASAL CONGESTION 64
289 STRESS 64
290 TREATMENT FAILURE 64
291 ACUTE MYELOID LEUKAEMIA 63
292 AGITATION 63
293 ALTERED STATE OF CONSCIOUSNESS 63
294 DRUG ERUPTION 63
295 INFLAMMATION 63
296 LEUKOPENIA 63
297 TRANSFUSION 63
298 CONVULSION 62
299 DEEP VEIN THROMBOSIS 62
300 DISEASE RECURRENCE 62
301 DISORIENTATION 62
302 PNEUMONIA ASPIRATION 62
303 PNEUMONITIS 62
304 BILE DUCT STONE 61
305 BRADYCARDIA 61
306 FAECES DISCOLOURED 60
307 HAEMATURIA 60
308 INJECTION SITE ERYTHEMA 60
309 LYMPHADENOPATHY 60
310 METABOLIC ACIDOSIS 60
311 MIGRAINE 60
312 OVERDOSE 60
313 RASH ERYTHEMATOUS 60
314 SURGERY 60
315 NEOPLASM MALIGNANT 59
316 BLOOD POTASSIUM DECREASED 58
317 CHRONIC GRAFT VERSUS HOST DISEASE 58
318 INSURANCE ISSUE 58
319 PULMONARY FUNCTION TEST DECREASED 58
320 HAEMATOCRIT DECREASED 57
321 INFLUENZA LIKE ILLNESS 57
322 SKIN DISCOLOURATION 57
323 TUBULOINTERSTITIAL NEPHRITIS 57
324 AMNESIA 56
325 BLOOD CHOLESTEROL INCREASED 56
326 HYPERURICAEMIA 56
327 NO ADVERSE EVENT 56
328 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 56
329 PRODUCT PRESCRIBING ERROR 56
330 RESPIRATORY DISORDER 56
331 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 56
332 UNEVALUABLE EVENT 56
333 AMMONIA INCREASED 55
334 HEPATIC STEATOSIS 55
335 OSTEOPOROSIS 55
336 SPEECH DISORDER 55
337 HALLUCINATION 54
338 POLLAKIURIA 54
339 EAR INFECTION 53
340 HYPOCALCAEMIA 53
341 MALNUTRITION 53
342 PULMONARY HYPERTENSION 53
343 ARRHYTHMIA 52
344 CEREBRAL INFARCTION 52
345 DEVICE RELATED INFECTION 52
346 GALLBLADDER DISORDER 52
347 IRON DEFICIENCY ANAEMIA 52
348 PROTEINURIA 52
349 SKIN LESION 52
350 EYE PAIN 51
351 GASTROENTERITIS 51
352 UPPER GASTROINTESTINAL HAEMORRHAGE 51
353 VANISHING BILE DUCT SYNDROME 51
354 BONE MARROW FAILURE 50
355 HEPATIC PAIN 50
356 PRE-ECLAMPSIA 50
357 PSORIASIS 50
358 SHOCK 50
359 SKIN EXFOLIATION 50
360 STEVENS-JOHNSON SYNDROME 50
361 ASPARTATE AMINOTRANSFERASE ABNORMAL 49
362 CATARACT 49
363 CHOLECYSTITIS 49
364 HYPOPHAGIA 49
365 UNDERDOSE 49
366 ACUTE HEPATIC FAILURE 48
367 ANGIOEDEMA 48
368 HYPOPHOSPHATAEMIA 48
369 ILL-DEFINED DISORDER 48
370 MOBILITY DECREASED 48
371 ORAL PAIN 48
372 PNEUMOCYSTIS JIROVECII PNEUMONIA 48
373 TASTE DISORDER 48
374 BLOOD POTASSIUM INCREASED 47
375 CARDIO-RESPIRATORY ARREST 47
376 CYTOMEGALOVIRUS INFECTION REACTIVATION 47
377 CYTOMEGALOVIRUS VIRAEMIA 47
378 DISCOMFORT 47
379 EATING DISORDER 47
380 INJECTION SITE PRURITUS 47
381 NORMAL NEWBORN 47
382 SWELLING FACE 47
383 CARDIAC DISORDER 46
384 EXPOSURE VIA BREAST MILK 46
385 GASTRITIS 46
386 HEPATORENAL SYNDROME 46
387 NEOPLASM PROGRESSION 46
388 PRURITUS GENERALISED 46
389 PULMONARY HAEMORRHAGE 46
390 VERTIGO 46
391 ADVERSE EVENT 45
392 BODY TEMPERATURE INCREASED 45
393 DYSURIA 45
394 MATERNAL EXPOSURE DURING BREAST FEEDING 45
395 WHEEZING 45
396 CLOSTRIDIUM DIFFICILE COLITIS 44
397 FEELING HOT 44
398 OSTEOARTHRITIS 44
399 PRODUCT ADMINISTRATION ERROR 44
400 STAPHYLOCOCCAL SEPSIS 44
401 TACHYPNOEA 44
402 BILE DUCT STENOSIS 43
403 BLISTER 43
404 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 43
405 DEPRESSED MOOD 43
406 DYSARTHRIA 43
407 HYPERAMMONAEMIA 43
408 LIVER TRANSPLANT REJECTION 43
409 VITAMIN D DEFICIENCY 43
410 ADRENAL INSUFFICIENCY 42
411 ATELECTASIS 42
412 DYSGEUSIA 42
413 HEART RATE DECREASED 42
414 LIVER ABSCESS 42
415 NECK PAIN 42
416 PNEUMOTHORAX 42
417 PULMONARY MALFORMATION 42
418 ASPERGILLUS INFECTION 41
419 BLOOD GLUCOSE DECREASED 41
420 BLOOD SODIUM DECREASED 41
421 CYSTITIS 41
422 DRUG LEVEL DECREASED 41
423 END STAGE RENAL DISEASE 41
424 ESCHERICHIA INFECTION 41
425 GENERALISED OEDEMA 41
426 HAEMOLYSIS 41
427 HEPATIC ENZYME ABNORMAL 41
428 HEPATOCELLULAR CARCINOMA 41
429 HIP FRACTURE 41
430 NEUROTOXICITY 41
431 OCULAR ICTERUS 41
432 PNEUMONIA BACTERIAL 41
433 RASH MACULO-PAPULAR 41
434 RESPIRATORY SYNCYTIAL VIRUS INFECTION 41
435 RESTLESSNESS 41
436 SERUM FERRITIN INCREASED 41
437 SMALL INTESTINAL OBSTRUCTION 41
438 ABNORMAL FAECES 40
439 BILE ACIDS INCREASED 40
440 BILIRUBIN CONJUGATED INCREASED 40
441 BRONCHOPULMONARY ASPERGILLOSIS 40
442 CHOLECYSTITIS ACUTE 40
443 CYSTITIS HAEMORRHAGIC 40
444 EYE IRRITATION 40
445 GASTROENTERITIS VIRAL 40
446 HAEMATOMA 40
447 LOW BIRTH WEIGHT BABY 40
448 SKIN ULCER 40
449 BLOOD MAGNESIUM DECREASED 39
450 BURNING SENSATION 39
451 ELECTROCARDIOGRAM QT PROLONGED 39
452 ERYTHEMA MULTIFORME 39
453 FLUID OVERLOAD 39
454 MOUTH ULCERATION 39
455 MUSCULOSKELETAL PAIN 39
456 NEURALGIA 39
457 OESOPHAGEAL VARICES HAEMORRHAGE 39
458 THERAPEUTIC RESPONSE DECREASED 39
459 ABNORMAL BEHAVIOUR 38
460 ACNE 38
461 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 38
462 DIVERTICULITIS 38
463 DRUG RESISTANCE 38
464 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 38
465 INTENTIONAL PRODUCT MISUSE 38
466 METASTASES TO LIVER 38
467 POST PROCEDURAL COMPLICATION 38
468 ABORTION SPONTANEOUS 37
469 ANAPHYLACTIC SHOCK 37
470 DRUG LEVEL INCREASED 37
471 FEEDING DISORDER 37
472 ILEUS 37
473 INJURY 37
474 INTENTIONAL DOSE OMISSION 37
475 NEPHROPATHY TOXIC 37
476 RESPIRATORY TRACT INFECTION 37
477 ABDOMINAL PAIN LOWER 36
478 FULL BLOOD COUNT DECREASED 36
479 HEPATITIS ACUTE 36
480 PRODUCT AVAILABILITY ISSUE 36
481 PRODUCT DOSE OMISSION IN ERROR 36
482 SHOCK HAEMORRHAGIC 36
483 SUICIDAL IDEATION 36
484 TUMOUR LYSIS SYNDROME 36
485 TYPE 2 DIABETES MELLITUS 36
486 ADENOVIRUS INFECTION 35
487 ALANINE AMINOTRANSFERASE ABNORMAL 35
488 CANDIDA INFECTION 35
489 CHOLESTASIS OF PREGNANCY 35
490 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 35
491 COMA 35
492 CRYING 35
493 IRRITABILITY 35
494 LACTIC ACIDOSIS 35
495 PORTAL VEIN THROMBOSIS 35
496 PRIMARY BILIARY CHOLANGITIS 35
497 PULMONARY ARTERIAL HYPERTENSION 35
498 BLOOD TEST ABNORMAL 34
499 GRAFT VERSUS HOST DISEASE IN SKIN 34
500 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 34
501 HEPATITIS CHOLESTATIC 34
502 LOWER RESPIRATORY TRACT INFECTION 34
503 NERVOUSNESS 34
504 PREGNANCY 34
505 SINUS TACHYCARDIA 34
506 SKIN DISORDER 34
507 BLOOD PRESSURE FLUCTUATION 33
508 BLOOD PRESSURE SYSTOLIC INCREASED 33
509 BLOOD URINE PRESENT 33
510 DUODENAL ULCER 33
511 ELECTROLYTE IMBALANCE 33
512 ENTERITIS 33
513 ENTEROCOLITIS 33
514 HOT FLUSH 33
515 HYPERSOMNIA 33
516 ORAL HERPES 33
517 SUBARACHNOID HAEMORRHAGE 33
518 THROAT IRRITATION 33
519 TINNITUS 33
520 CHOLECYSTECTOMY 32
521 DYSSTASIA 32
522 HEPATIC NECROSIS 32
523 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 32
524 INCREASED APPETITE 32
525 JAUNDICE CHOLESTATIC 32
526 RESPIRATORY ARREST 32
527 RHINITIS 32
528 SINUS DISORDER 32
529 THERAPY PARTIAL RESPONDER 32
530 URINE OUTPUT DECREASED 32
531 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 31
532 AGGRESSION 31
533 AUTOIMMUNE DISORDER 31
534 DEMENTIA 31
535 DISTURBANCE IN ATTENTION 31
536 EMOTIONAL DISTRESS 31
537 ESCHERICHIA BACTERAEMIA 31
538 FEMUR FRACTURE 31
539 HALLUCINATION, VISUAL 31
540 MENTAL DISORDER 31
541 NIGHT SWEATS 31
542 ORTHOSTATIC HYPOTENSION 31
543 PAIN IN JAW 31
544 PROCTALGIA 31
545 PURPURA 31
546 SCRATCH 31
547 APHASIA 30
548 APHTHOUS ULCER 30
549 BLOOD TRIGLYCERIDES INCREASED 30
550 CHOLANGIOCARCINOMA 30
551 CYTOMEGALOVIRUS TEST POSITIVE 30
552 ENTEROCOCCAL INFECTION 30
553 EPILEPSY 30
554 GASTROINTESTINAL INFECTION 30
555 HAEMORRHOIDS 30
556 HEPATITIS C 30
557 HERNIA 30
558 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 30
559 INJECTION SITE HAEMORRHAGE 30
560 OCULAR HYPERAEMIA 30
561 ORGANISING PNEUMONIA 30
562 PHOTOPHOBIA 30
563 PRODUCT QUALITY ISSUE 30
564 PULMONARY CONGESTION 30
565 WEIGHT FLUCTUATION 30
566 BLOOD AMYLASE INCREASED 29
567 CONJUNCTIVITIS 29
568 COVID-19 PNEUMONIA 29
569 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 29
570 EOSINOPHIL COUNT INCREASED 29
571 GASTROINTESTINAL INFLAMMATION 29
572 HEAD INJURY 29
573 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 29
574 MITRAL VALVE INCOMPETENCE 29
575 MUSCULOSKELETAL CHEST PAIN 29
576 OESOPHAGITIS 29
577 ORAL CANDIDIASIS 29
578 PALLOR 29
579 PRESYNCOPE 29
580 SUBDURAL HAEMATOMA 29
581 SYSTEMIC LUPUS ERYTHEMATOSUS 29
582 BLINDNESS 28
583 BLOOD IRON DECREASED 28
584 BLOOD URIC ACID INCREASED 28
585 BOWEL MOVEMENT IRREGULARITY 28
586 COGNITIVE DISORDER 28
587 ERUCTATION 28
588 FAECES SOFT 28
589 FOOD ALLERGY 28
590 GAIT INABILITY 28
591 HYPERVOLAEMIA 28
592 IMMUNOSUPPRESSION 28
593 LUNG INFECTION 28
594 MIDDLE INSOMNIA 28
595 MYELODYSPLASTIC SYNDROME 28
596 PNEUMONIA CYTOMEGALOVIRAL 28
597 PNEUMONIA FUNGAL 28
598 RESPIRATORY TRACT MALFORMATION 28
599 TRANSPLANT REJECTION 28
600 CAESAREAN SECTION 27
601 CARDIAC FAILURE ACUTE 27
602 FLANK PAIN 27
603 FOETAL GROWTH RESTRICTION 27
604 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 27
605 IRON OVERLOAD 27
606 LUNG CYST 27
607 LUNG TRANSPLANT 27
608 METASTASES TO LUNG 27
609 MYOCARDITIS 27
610 MYOSITIS 27
611 NERVOUS SYSTEM DISORDER 27
612 OSTEOPENIA 27
613 PLATELET COUNT INCREASED 27
614 PRODUCT DISTRIBUTION ISSUE 27
615 RENAL INJURY 27
616 STAPHYLOCOCCAL BACTERAEMIA 27
617 THERAPEUTIC PRODUCT EFFECT DECREASED 27
618 ULCER 27
619 BK VIRUS INFECTION 26
620 BLOOD GLUCOSE ABNORMAL 26
621 BRAIN OEDEMA 26
622 FACE OEDEMA 26
623 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 26
624 GASTRIC DISORDER 26
625 HYPERCALCAEMIA 26
626 HYPOACUSIS 26
627 INJECTION SITE BRUISING 26
628 INTERNAL HAEMORRHAGE 26
629 INTRACRANIAL PRESSURE INCREASED 26
630 PORTAL HYPERTENSIVE GASTROPATHY 26
631 POST-TRAUMATIC STRESS DISORDER 26
632 RASH MACULAR 26
633 RHINOVIRUS INFECTION 26
634 SEASONAL ALLERGY 26
635 URINARY INCONTINENCE 26
636 VASCULITIS 26
637 ACCIDENTAL OVERDOSE 25
638 ANOREXIA 25
639 ATRIAL SEPTAL DEFECT 25
640 BILIARY TRACT DISORDER 25
641 CHOLANGITIS ACUTE 25
642 CIRCULATORY COLLAPSE 25
643 DEAFNESS 25
644 ENCEPHALITIS 25
645 EYE PRURITUS 25
646 FULL BLOOD COUNT ABNORMAL 25
647 IRON DEFICIENCY 25
648 LIMB INJURY 25
649 POST PROCEDURAL HAEMORRHAGE 25
650 PRESCRIBED UNDERDOSE 25
651 PROTHROMBIN TIME PROLONGED 25
652 RENAL TUBULAR NECROSIS 25
653 UPPER LIMB FRACTURE 25
654 APPENDICITIS 24
655 BILIARY TRACT INFECTION 24
656 BLOOD COUNT ABNORMAL 24
657 DEVICE MALFUNCTION 24
658 DIARRHOEA HAEMORRHAGIC 24
659 DRUG LEVEL BELOW THERAPEUTIC 24
660 EOSINOPHILIA 24
661 GASTRIC HAEMORRHAGE 24
662 HAEMOSIDEROSIS 24
663 HEAD DISCOMFORT 24
664 HEPATITIS TOXIC 24
665 HOSPICE CARE 24
666 HYDRONEPHROSIS 24
667 HYPERNATRAEMIA 24
668 IMPAIRED GASTRIC EMPTYING 24
669 IMPAIRED HEALING 24
670 INCONTINENCE 24
671 INFUSION SITE ERYTHEMA 24
672 LIPASE INCREASED 24
673 LOCALISED INFECTION 24
674 MEDICATION ERROR 24
675 PERITONITIS 24
676 PETECHIAE 24
677 PNEUMONIA STAPHYLOCOCCAL 24
678 PULMONARY ALVEOLAR HAEMORRHAGE 24
679 RENAL CYST 24
680 RIGHT VENTRICULAR FAILURE 24
681 ROAD TRAFFIC ACCIDENT 24
682 SPINAL FRACTURE 24
683 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 23
684 ANGER 23
685 BLOOD LOSS ANAEMIA 23
686 CAPILLARY LEAK SYNDROME 23
687 CARDIOMEGALY 23
688 CHEILITIS 23
689 DERMATITIS ACNEIFORM 23
690 DIPLOPIA 23
691 EAR PAIN 23
692 ENTEROCOCCAL SEPSIS 23
693 EYE DISORDER 23
694 FAECAL CALPROTECTIN INCREASED 23
695 GLOMERULAR FILTRATION RATE DECREASED 23
696 HEPATOSPLENOMEGALY 23
697 HYPERTHYROIDISM 23
698 IMMUNODEFICIENCY 23
699 INFUSION SITE PAIN 23
700 LYMPHOCYTE STIMULATION TEST POSITIVE 23
701 MOUTH HAEMORRHAGE 23
702 MUSCLE ATROPHY 23
703 OBESITY 23
704 OSTEOMYELITIS 23
705 PLASMA CELL MYELOMA 23
706 PLATELET COUNT ABNORMAL 23
707 PROCEDURAL PAIN 23
708 PULMONARY MASS 23
709 RASH PAPULAR 23
710 STEM CELL TRANSPLANT 23
711 WEIGHT GAIN POOR 23
712 WRONG PRODUCT ADMINISTERED 23
713 ACUTE MYOCARDIAL INFARCTION 22
714 BILIARY CIRRHOSIS 22
715 BILIARY CIRRHOSIS PRIMARY 22
716 BRAIN FOG 22
717 DEVICE ISSUE 22
718 GINGIVAL BLEEDING 22
719 GLYCOSYLATED HAEMOGLOBIN INCREASED 22
720 HAEMODIALYSIS 22
721 HEPATITIS B 22
722 HYPERTRANSAMINASAEMIA 22
723 IMMUNE-MEDIATED ENTEROCOLITIS 22
724 IMMUNE-MEDIATED HEPATIC DISORDER 22
725 INABILITY TO AFFORD MEDICATION 22
726 INJECTION SITE SWELLING 22
727 LACTATION DISORDER 22
728 LIP PRURITUS 22
729 MAJOR DEPRESSION 22
730 MOOD SWINGS 22
731 NOCTURIA 22
732 PULMONARY TOXICITY 22
733 SCAB 22
734 WOUND 22
735 ACUTE LYMPHOCYTIC LEUKAEMIA 21
736 ACUTE MYELOID LEUKAEMIA RECURRENT 21
737 AGEUSIA 21
738 BONE MARROW TRANSPLANT 21
739 COLD SWEAT 21
740 DERMATITIS 21
741 DRUG WITHDRAWAL SYNDROME NEONATAL 21
742 DYSKINESIA 21
743 FORCED EXPIRATORY VOLUME DECREASED 21
744 HAEMOLYTIC ANAEMIA 21
745 HEPATIC CANCER 21
746 HEPATIC INFECTION 21
747 HEPATITIS FULMINANT 21
748 HYPERLIPIDAEMIA 21
749 IRRITABLE BOWEL SYNDROME 21
750 LEUKOCYTOSIS 21
751 NEPHROTIC SYNDROME 21
752 NO THERAPEUTIC RESPONSE 21
753 NON-SMALL CELL LUNG CANCER 21
754 PERIPHERAL COLDNESS 21
755 PYELONEPHRITIS 21
756 RED BLOOD CELL SEDIMENTATION RATE INCREASED 21
757 RETCHING 21
758 RIB FRACTURE 21
759 SPINAL COMPRESSION FRACTURE 21
760 SPUTUM INCREASED 21
761 THERAPEUTIC RESPONSE SHORTENED 21
762 THERAPEUTIC RESPONSE UNEXPECTED 21
763 VAGINAL HAEMORRHAGE 21
764 VISUAL ACUITY REDUCED 21
765 ALLERGIC SINUSITIS 20
766 ANGINA PECTORIS 20
767 ANURIA 20
768 BILE DUCT OBSTRUCTION 20
769 BLOOD PRESSURE ABNORMAL 20
770 BONE DISORDER 20
771 BRONCHIECTASIS 20
772 CARDIAC FAILURE CHRONIC 20
773 CARDIOMYOPATHY 20
774 COMPRESSION FRACTURE 20
775 CYANOSIS 20
776 DIALYSIS 20
777 FOOT FRACTURE 20
778 HAEMORRHAGE INTRACRANIAL 20
779 HYPERTRIGLYCERIDAEMIA 20
780 IMMUNE-MEDIATED HEPATITIS 20
781 KLEBSIELLA INFECTION 20
782 LIP SWELLING 20
783 LOWER LIMB FRACTURE 20
784 NEPHROGENIC ANAEMIA 20
785 PANCREATITIS RELAPSING 20
786 PANIC ATTACK 20
787 POOR QUALITY SLEEP 20
788 PROCTITIS 20
789 PRODUCT SUBSTITUTION ISSUE 20
790 PSEUDOMONAS TEST POSITIVE 20
791 SKIN FISSURES 20
792 ANAL INCONTINENCE 19
793 ASPIRATION 19
794 BLOOD CULTURE POSITIVE 19
795 CACHEXIA 19
796 CFTR GENE MUTATION 19
797 CHOLECYSTITIS CHRONIC 19
798 CHOLESTATIC LIVER INJURY 19
799 COLECTOMY 19
800 DERMATITIS ATOPIC 19
801 FEELING COLD 19
802 GRAFT VERSUS HOST DISEASE IN LIVER 19
803 IMMUNE SYSTEM DISORDER 19
804 JOINT STIFFNESS 19
805 KIDNEY FIBROSIS 19
806 MENTAL IMPAIRMENT 19
807 OLIGURIA 19
808 PLATELET TRANSFUSION 19
809 PNEUMONIA VIRAL 19
810 POOR VENOUS ACCESS 19
811 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 19
812 PRODUCT PRESCRIBING ISSUE 19
813 SECRETION DISCHARGE 19
814 SKIN LACERATION 19
815 SUPRAVENTRICULAR TACHYCARDIA 19
816 THERAPY CHANGE 19
817 THROAT TIGHTNESS 19
818 TRICUSPID VALVE INCOMPETENCE 19
819 YELLOW SKIN 19
820 ACIDOSIS 18
821 ARTHROPATHY 18
822 BILIARY OBSTRUCTION 18
823 BLOOD BILIRUBIN ABNORMAL 18
824 BODY TEMPERATURE DECREASED 18
825 DISSEMINATED ASPERGILLOSIS 18
826 DRUG EFFECT DECREASED 18
827 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18
828 DRUG EXPOSURE DURING PREGNANCY 18
829 EYE SWELLING 18
830 GOUT 18
831 HIATUS HERNIA 18
832 HISTIOCYTOSIS HAEMATOPHAGIC 18
833 HYPERPHOSPHATAEMIA 18
834 INJECTION SITE REACTION 18
835 KIDNEY INFECTION 18
836 LACRIMATION INCREASED 18
837 LARGE INTESTINE PERFORATION 18
838 LARGE INTESTINE POLYP 18
839 LOWER GASTROINTESTINAL HAEMORRHAGE 18
840 MASS 18
841 MATERNAL DRUGS AFFECTING FOETUS 18
842 MOOD ALTERED 18
843 MUSCLE TWITCHING 18
844 NEPHROPATHY 18
845 PARTIAL SEIZURES 18
846 PHARYNGITIS 18
847 PHARYNGITIS STREPTOCOCCAL 18
848 POLYMYOSITIS 18
849 PSEUDOMEMBRANOUS COLITIS 18
850 STEROID DIABETES 18
851 SYSTEMIC CANDIDA 18
852 TOXIC ENCEPHALOPATHY 18
853 ABDOMINAL MASS 17
854 BASAL CELL CARCINOMA 17
855 BREAST CANCER 17
856 BRONCHIOLITIS 17
857 CARDIOGENIC SHOCK 17
858 DENTAL CARIES 17
859 DEVICE OCCLUSION 17
860 EJECTION FRACTION DECREASED 17
861 ENGRAFTMENT SYNDROME 17
862 EPSTEIN-BARR VIRUS INFECTION 17
863 FAILURE TO THRIVE 17
864 FISTULA 17
865 GALLBLADDER ENLARGEMENT 17
866 GASTRIC CANCER 17
867 HAEMORRHOIDAL HAEMORRHAGE 17
868 HEPATIC MASS 17
869 HICCUPS 17
870 LEUKAEMIA 17
871 LUNG INFILTRATION 17
872 LUNG NEOPLASM MALIGNANT 17
873 LYMPHOMA 17
874 METASTASES TO BONE 17
875 MYOPATHY 17
876 POOR SUCKING REFLEX 17
877 POSTOPERATIVE WOUND INFECTION 17
878 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 17
879 PSYCHOMOTOR HYPERACTIVITY 17
880 RASH GENERALISED 17
881 SCAR 17
882 SJOGREN^S SYNDROME 17
883 SKIN CANCER 17
884 SKIN HYPERPIGMENTATION 17
885 SKIN PAPILLOMA 17
886 SLEEP APNOEA SYNDROME 17
887 TOOTH EXTRACTION 17
888 TRANSPLANT FAILURE 17
889 WHITE BLOOD CELL COUNT ABNORMAL 17
890 ACCIDENTAL EXPOSURE TO PRODUCT 16
891 ARTHRITIS BACTERIAL 16
892 AZOTAEMIA 16
893 B-CELL LYMPHOMA 16
894 BLOOD CALCIUM DECREASED 16
895 BLOOD PHOSPHORUS DECREASED 16
896 CARPAL TUNNEL SYNDROME 16
897 CHRONIC HEPATIC FAILURE 16
898 COMPLICATION ASSOCIATED WITH DEVICE 16
899 DIABETES MELLITUS INADEQUATE CONTROL 16
900 DISEASE COMPLICATION 16
901 DRUG EFFECT LESS THAN EXPECTED 16
902 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 16
903 ESCHERICHIA URINARY TRACT INFECTION 16
904 FAECES PALE 16
905 FIBROMYALGIA 16
906 GESTATIONAL DIABETES 16
907 HAEMOGLOBIN ABNORMAL 16
908 HEART RATE IRREGULAR 16
909 HEPATOCELLULAR INJURY 16
910 HERPES SIMPLEX 16
911 ILEUS PARALYTIC 16
912 INJECTION SITE MASS 16
913 INTERVERTEBRAL DISC DEGENERATION 16
914 INTRA-ABDOMINAL FLUID COLLECTION 16
915 JOINT RANGE OF MOTION DECREASED 16
916 KLEBSIELLA BACTERAEMIA 16
917 LIP DRY 16
918 LOCALISED OEDEMA 16
919 LYMPHOPENIA 16
920 MALABSORPTION 16
921 MANIA 16
922 METASTASES TO CENTRAL NERVOUS SYSTEM 16
923 METASTASES TO SKIN 16
924 OBSTRUCTIVE AIRWAYS DISORDER 16
925 OESOPHAGEAL ACHALASIA 16
926 OSTEONECROSIS 16
927 PARENTERAL NUTRITION 16
928 PELVIC FRACTURE 16
929 PEMPHIGOID 16
930 PHYSICAL DECONDITIONING 16
931 PREMATURE LABOUR 16
932 PRODUCT USE COMPLAINT 16
933 RALES 16
934 RESPIRATION ABNORMAL 16
935 SKIN BURNING SENSATION 16
936 STEATORRHOEA 16
937 THIRST 16
938 TOXIC SKIN ERUPTION 16
939 TRANSIENT ISCHAEMIC ATTACK 16
940 TYPE 1 DIABETES MELLITUS 16
941 UNRESPONSIVE TO STIMULI 16
942 VARICELLA ZOSTER VIRUS INFECTION 16
943 VENTRICULAR TACHYCARDIA 16
944 ABDOMINAL TENDERNESS 15
945 ABSCESS 15
946 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 15
947 APHONIA 15
948 AUTOIMMUNE HAEMOLYTIC ANAEMIA 15
949 AXONAL NEUROPATHY 15
950 BEDRIDDEN 15
951 BILIARY DILATATION 15
952 BLOOD CALCIUM INCREASED 15
953 BLOOD CREATININE DECREASED 15
954 DECREASED ACTIVITY 15
955 DEVICE RELATED BACTERAEMIA 15
956 DEVICE RELATED SEPSIS 15
957 GASTROINTESTINAL SOUNDS ABNORMAL 15
958 GASTROINTESTINAL ULCER 15
959 GENERALISED TONIC-CLONIC SEIZURE 15
960 GINGIVITIS 15
961 HAEMATOLOGICAL INFECTION 15
962 HEMIPARESIS 15
963 HEPATIC LESION 15
964 HUMAN HERPESVIRUS 6 INFECTION 15
965 INGUINAL HERNIA 15
966 INTESTINAL PERFORATION 15
967 LIVE BIRTH 15
968 METASTASES TO LYMPH NODES 15
969 MOVEMENT DISORDER 15
970 NEUTROPHIL COUNT INCREASED 15
971 PAPULE 15
972 PARAINFLUENZAE VIRUS INFECTION 15
973 PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA 15
974 POLYNEUROPATHY 15
975 POUCHITIS 15
976 PROSTATE CANCER 15
977 PULMONARY THROMBOSIS 15
978 REBOUND EFFECT 15
979 RESPIRATORY TRACT CONGESTION 15
980 RETINAL HAEMORRHAGE 15
981 SINUS BRADYCARDIA 15
982 SKIN ATROPHY 15
983 SUSPECTED OFF LABEL USE 15
984 VENTRICULAR FIBRILLATION 15
985 VITAMIN D DECREASED 15
986 APLASIA PURE RED CELL 14
987 ATRIAL FLUTTER 14
988 BLOOD CREATINE INCREASED 14
989 CARDIAC MURMUR 14
990 COMPLETED SUICIDE 14
991 COMPLICATIONS OF TRANSPLANTED LIVER 14
992 CONCOMITANT DISEASE AGGRAVATED 14
993 CONTRAINDICATED PRODUCT ADMINISTERED 14
994 DERMATITIS CONTACT 14
995 DIASTOLIC DYSFUNCTION 14
996 DIZZINESS POSTURAL 14
997 DRUG WITHDRAWAL SYNDROME 14
998 FIBROSIS 14
999 GASTROENTERITIS NOROVIRUS 14